In support of cardiac chronotropic beta 2 adrenoceptors

Area of Science:

• Cardiovascular Pharmacology
• Exercise Physiology

Background:

• Beta-adrenergic receptors play crucial roles in regulating heart rate and response to stimuli.
• Cardioselective (beta-1) and nonselective (beta-1 and beta-2) beta-blockers have distinct effects on cardiovascular function.

Purpose of the Study:

• To compare the effects of atenolol (cardioselective) and propranolol (nonselective) on exercise- and isoproterenol-induced heart rate changes.
• To investigate the potential role of cardiac beta-2 receptors in heart rate regulation.

Main Methods:

• Nine male volunteers received placebo, atenolol (50 mg), or propranolol (40 mg).
• Heart rate responses to submaximal exercise and intravenous isoproterenol infusion were measured.
• Isoproterenol sensitivity was assessed by the dose required to increase heart rate by 25 beats/min (CD-25).
• The effect of atropine on isoproterenol CD-25 was evaluated.

Main Results:

• Both atenolol and propranolol equally reduced maximal exercise heart rate.
• Propranolol significantly increased isoproterenol CD-25 more than atenolol, indicating greater antagonism of isoproterenol's effects.
• Atropine did not affect isoproterenol CD-25 with placebo or atenolol but decreased it with propranolol, suggesting propranolol's nonselective action.

Conclusions:

• Moderate exercise heart rate is primarily mediated by beta-1 receptors, equally blocked by both drug types.
• Isoproterenol stimulates both beta-1 and beta-2 receptors.
• The data suggest the presence of cardiac beta-2 chronotropic receptors, though their physiological significance requires further study.